logo
  

Stellantis In Deal With Samsung SDI To Form North American JV To Produce Lithium-Ion Battery

Automaker Stellantis N.V. (STLA) announced Friday that it has entered into a memorandum of understanding with rechargeable battery maker Samsung SDI to form a joint venture to produce lithium-ion battery cells and modules for North America.

The transaction is subject to agreement on definitive documentation and customary closing conditions, including regulatory approvals.

The location of the new facility is currently under review and the companies will share further details at a later date. The new battery plant is targeted to start in 2025. It aims to have an initial annual production capacity of 23 gigawatt hours, with the ability to increase up to 40 gigawatt hours in the future.

Stellantis said it is now well advanced in the process of securing annual production capacity for electric vehicle batteries. This will result in achieving 40% of its sales in the U.S. comprised of electrified vehicles by 2030.

The battery plants will fulfill the needs of Stellantis assembly plants throughout the US, Canada, and Mexico for installation in next-generation electric vehicles.

Stellantis plans to invest more than 30 billion euros through 2025 in electrification and software development.

Young-hyun Jun, President and CEO of Samsung SDI, said, "With this battery joint venture, we will do our best to meet the high standards of our customers in the North American EV market leveraging Samsung SDI's battery technology, high quality products and safety measures."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
This Black Friday and the following holiday season, retailers across the United States are urged to keep up their inventory amid expected surge in shopping as majority of Americans wait till last minute to fill their baskets, according to certain studies. A new Oracle Retail survey, which was conducted last week and presented earlier this week, showed that 66 percent of consumers were less than Eagle, Idaho -based Flagship Food Group is recalling certain TJ Farms Select brand frozen cauliflower, citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves a limited number of cases of TJ Farms Select cauliflower that comes in 16 oz. packages with lot code 2077890089 and UPC code 75544000604-3. The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals Co. Ltd.'s Livtencity (maribavir) as the first drug to treat post-transplant cytomegalovirus or CMV in adults and pediatric patients. The approval is to treat patients 12 years of age and older and weighing at least 35 kilograms with post-transplant CMV infection/disease that does not respond...
Follow RTT